Molecular Partners AG
MOLN4.380USD
-0.010-0.23%
收盤 12/22, 16:00（美東）報價延遲15分鐘
163.81M總市值
虧損本益比TTM
關於 Molecular Partners AG 公司
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AG簡介
公司代碼MOLN
公司名稱Molecular Partners AG
上市日期Oct 22, 2014
CEOAmstutz (Patrick)
員工數量159
證券類型Depository Receipt
年結日Oct 22
公司地址Wagistrasse 14
城市SCHLIEREN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Switzerland
郵編8952
電話41447557700
網址https://www.molecularpartners.com/
公司代碼MOLN
上市日期Oct 22, 2014
CEOAmstutz (Patrick)
Molecular Partners AG公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Renate Gloggner
Ms. Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Executive Vice President - People and Community, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Alexander Zuercher
Mr. Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
Switzerland
4.97M
0.00%
United States
0.00
0.00%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 8月17日 週日
更新時間: 8月17日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
UBS Financial Services, Inc.
0.01%
其他
90.43%
持股股東
持股股東
佔比
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
UBS Financial Services, Inc.
0.01%
其他
90.43%
股東類型
持股股東
佔比
Hedge Fund
9.56%
Investment Advisor
0.01%
其他
90.42%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
15
3.59M
9.59%
-23.51K
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
2023Q2
36
934.21K
2.85%
-1.24M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Suvretta Capital Management, LLC
2.22M
6.03%
--
--
Jun 30, 2025
BVF Partners L.P.
1.35M
3.67%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
10.20K
0.03%
+3.85K
+60.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
Aug 31, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Jun 30, 2025
EverSource Wealth Advisors, LLC
41.00
0%
+41.00
--
Jun 30, 2025
BofA Global Research (US)
157.00
0%
--
--
Jun 30, 2025
Rhumbline Advisers Ltd. Partnership
--
0%
-269.00
-100.00%
Jun 30, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
Old Mission Capital LLC
--
0%
-10.37K
-100.00%
Sep 30, 2024
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Molecular Partners AG的前五大股東是誰？
Molecular Partners AG的前五大股東如下：
Suvretta Capital Management, LLC持有股份：2.22M佔總股份比例：6.03%。
BVF Partners L.P.持有股份：1.35M佔總股份比例：3.67%。
UBS Financial Services, Inc.持有股份：10.20K佔總股份比例：0.03%。
Geode Capital Management, L.L.C.持有股份：1.07K佔總股份比例：0.00%。
Morgan Stanley & Co. LLC持有股份：367.00佔總股份比例：0.00%。
Suvretta Capital Management, LLC持有股份：2.22M佔總股份比例：6.03%。
BVF Partners L.P.持有股份：1.35M佔總股份比例：3.67%。
UBS Financial Services, Inc.持有股份：10.20K佔總股份比例：0.03%。
Geode Capital Management, L.L.C.持有股份：1.07K佔總股份比例：0.00%。
Morgan Stanley & Co. LLC持有股份：367.00佔總股份比例：0.00%。
Molecular Partners AG的前三大股東類型是什麼？
Molecular Partners AG 的前三大股東類型分別是：
Suvretta Capital Management, LLC
BVF Partners L.P.
UBS Financial Services, Inc.
Suvretta Capital Management, LLC
BVF Partners L.P.
UBS Financial Services, Inc.
有多少機構持有Molecular Partners AG(MOLN)的股份？
截至2025Q3，共有15家機構持有Molecular Partners AG的股份，合計持有的股份價值約為3.59M，占公司總股份的9.59% 。與2025Q2相比，機構持股有所增加，增幅為-0.13%。
哪個業務部門對Molecular Partners AG的收入貢獻最大？
在FY2024，--業務部門對Molecular Partners AG的收入貢獻最大，創收--，占總收入的--% 。
